Comparison of cautery and laser in polycystic ovary syndrome patients

Comparison of the effects of laparoscopic ovarian drilling on ovarian reserve using unipolar cautery or CO2 laser in infertile patients with polycystic ovary syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017091636164N1

Enrollment

Registered

2017-11-05

Start date

2016-04-25

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poly cystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention 1 Laparoscopic ovarian drilling by uni polar cautery will be performed in group 1 . In this method , 15 points of unipolar cautery ( Karl Storz - Germany) will be appl

Treatment - Surgery

Intervention 1 Laparoscopic ovarian drilling by uni polar cautery will be performed in group 1 . In this method , 15 points of unipolar cautery ( Karl Storz - Germany) will be applied with grade

Intervention 2 laparoscopic ovarian drilling by CO2 Laser ( Ompilas ,Ziess ) will be done for group 2 . In this method 25 points on the medial aspect of ovary will be cauterized.

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were as follow: Having 2 criteria from 3 of Rotterdam criteria for diagnosis of PCOD; oligomenorrhea or amenorrhea; Clinical or biochemical evidence of hyperandrogenism; Sonographic findings of polycyctic ovary ( more than 10 primary follicle in each ovary) Exclusion criteria: Positive history of previous pelvic surgery; Evidence of pelvic adhesion; Evidence of pelvic organ abnormality; Pregnancy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum Anti Mullerian hormone levels. Timepoint: Three and 6 months after operation. Method of measurement: Serum AMH levels by Gen II ELIZA.;Serum Inhibin B levels. Timepoint: Three and 6 months after operation. Method of measurement: Serum Inhibin B levels by ELIZA Gen II.	—

Secondary

Measure	Time frame
Serum FSH level. Timepoint: Three and 6 months after operation. Method of measurement: Solid-phase sandwich enzyme- immunoassay.;Serum LH level. Timepoint: Three and 6 months after operation. Method of measurement: Solid-phase sandwich enzyme- immunoassay.;Serum total testestrone level. Timepoint: Three and 6 months after operation. Method of measurement: ELIZA.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Moghadami

Tehran University of Medical Sciences

n_moghadami@ sina.tums.ac.ir+98 21 8876 2345

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026